spacer
spacer

PDBsum entry 3idy

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Immune system PDB id
3idy

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
306 a.a. *
229 a.a. *
214 a.a. *
Ligands
NAG ×28
SO4
Waters ×152
* Residue conservation analysis
PDB id:
3idy
Name: Immune system
Title: Crystal structure of HIV-gp120 core in complex with cd4-binding site antibody b13, space group c2221
Structure: HIV-1 hxbc2 gp120 core. Chain: g, a. Engineered: yes. Mutation: yes. Fab b13 heavy chain. Chain: h, b. Engineered: yes. Fab b13 light chain. Chain: l, c.
Source: Human immunodeficiency virus 1. Organism_taxid: 11676. Strain: hxbc2. Gene: env. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293f. Homo sapiens. Human.
Resolution:
3.20Å     R-factor:   0.198     R-free:   0.237
Authors: L.Chen,Y.D.Kwon,T.Zhou,X.Wu,S.O'Dell,L.Cavacini,A.J.Hessell, M.Pancera,M.Tang,L.Xu,Z.Y.Yang,M.Y.Zhang,J.Arthos,D.R.Burton, D.S.Dimitrov,G.J.Nabel,M.Posner,J.Sodroski,R.Wyatt,J.R.Mascola, P.D.Kwong
Key ref:
L.Chen et al. (2009). Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120. Science, 326, 1123-1127. PubMed id: 19965434 DOI: 10.1126/science.1175868
Date:
22-Jul-09     Release date:   17-Nov-09    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P04578  (ENV_HV1H2) -  Envelope glycoprotein gp160 from Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Seq:
Struc:
 
Seq:
Struc:
856 a.a.
306 a.a.*
Protein chains
No UniProt id for this chain
Struc: 229 a.a.
Protein chains
No UniProt id for this chain
Struc: 214 a.a.
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 12 residue positions (black crosses)

 

 
DOI no: 10.1126/science.1175868 Science 326:1123-1127 (2009)
PubMed id: 19965434  
 
 
Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120.
L.Chen, Y.Do Kwon, T.Zhou, X.Wu, S.O'Dell, L.Cavacini, A.J.Hessell, M.Pancera, M.Tang, L.Xu, Z.Y.Yang, M.Y.Zhang, J.Arthos, D.R.Burton, D.S.Dimitrov, G.J.Nabel, M.R.Posner, J.Sodroski, R.Wyatt, J.R.Mascola, P.D.Kwong.
 
  ABSTRACT  
 
The site on HIV-1 gp120 that binds to the CD4 receptor is vulnerable to antibodies. However, most antibodies that interact with this site cannot neutralize HIV-1. To understand the basis of this resistance, we determined co-crystal structures for two poorly neutralizing, CD4-binding site (CD4BS) antibodies, F105 and b13, in complexes with gp120. Both antibodies exhibited approach angles to gp120 similar to those of CD4 and a rare, broadly neutralizing CD4BS antibody, b12. Slight differences in recognition, however, resulted in substantial differences in F105- and b13-bound conformations relative to b12-bound gp120. Modeling and binding experiments revealed these conformations to be poorly compatible with the viral spike. This incompatibility, the consequence of slight differences in CD4BS recognition, renders HIV-1 resistant to all but the most accurately targeted antibodies.
 
  Selected figure(s)  
 
Figure 2.
View larger version (50K): [in this window] [in a new window] Fig. 2. Epitopes, bound conformations, and trimer modeling. (A) Epitope hydrophobicity. The surface of gp120 is shown in gray, with hydrophobic residues highlighted in green. Binding surfaces for CD4, F105, b12, and b13 are outlined in orange. (B) Ligand-bound conformation of gp120. Polypeptides of gp120 are depicted in ribbon representation with inner domains shown in light gray, outer domains in dark gray, and regions that in the CD4-bound state correspond to the bridging sheet shown in red. Residues 109 and 428 are highlighted in blue and shown in stick representation. (C) Viral spike compatibility. Density maps derived from the cryo–electron tomography of HIV-1 BaL isolate spike are shown in gray for CD4 and 17b- and b12-bound states (first and third from left, respectively), along with optimal fits of atomic-level models (30). To model F105- and b13-bound forms of gp120 into likely viral spike orientations, the invariant β-sandwich of the gp120 inner domain was superimposed. Likely clashes of V1/V2 in the superimposed conformation with neighboring protomers close to the trimer axis are highlighted in light blue.
Figure 3.
View larger version (42K): [in this window] [in a new window] Fig. 3. Immune evasion at the site of initial CD4 attachment. (A) Recognition similarity. Centers of recognition for CD4, F105, b12, and b13. After superposition of gp120 outer domains, the centers of the recognition surface of each ligand on gp120 is denoted by balls for CD4 (yellow), F105 (blue), b12 (red), and b13 (purple). (B) Immune evasion. The initial site of CD4 attachment (cross-hatched yellow surface) is circumscribed by a combination of glycan (green) and conformational constraints. The surface on gp120 recognized by F105, b12, and b13 (that strays beyond the site of CD4 attachment) is shown in blue, red, and purple, respectively. Glycosylation sterically crowds the immune response toward the bridging-sheet region (blue surface that F105 recognizes) or toward the V3 region (purple surface that b13 recognizes) (48). In either case, recognition of these regions of gp120 results in antibody-bound conformations of gp120 that are poorly compatible with the functional spikes of HIV-1 virions from tier 2 primary isolates.
 
  The above figures are reprinted by permission from the AAAs: Science (2009, 326, 1123-1127) copyright 2009.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21117239 A.Emileh, and C.F.Abrams (2011).
A mechanism by which binding of the broadly neutralizing antibody b12 unfolds the inner domain α1 helix in an engineered HIV-1 gp120.
  Proteins, 79, 537-546.  
21357743 C.R.Ruprecht, A.Krarup, L.Reynell, A.M.Mann, O.F.Brandenberg, L.Berlinger, I.A.Abela, R.R.Regoes, H.F.Günthard, P.Rusert, and A.Trkola (2011).
MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1.
  J Exp Med, 208, 439-454.  
21249232 I.Mikell, D.N.Sather, S.A.Kalams, M.Altfeld, G.Alter, and L.Stamatatos (2011).
Characteristics of the earliest cross-neutralizing antibody response to HIV-1.
  PLoS Pathog, 7, e1001251.  
22113616 J.S.McLellan, M.Pancera, C.Carrico, J.Gorman, J.P.Julien, R.Khayat, R.Louder, R.Pejchal, M.Sastry, K.Dai, S.O'Dell, N.Patel, S.Shahzad-ul-Hussan, Y.Yang, B.Zhang, T.Zhou, J.Zhu, J.C.Boyington, G.Y.Chuang, D.Diwanji, I.Georgiev, Y.D.Kwon, D.Lee, M.K.Louder, S.Moquin, S.D.Schmidt, Z.Y.Yang, M.Bonsignori, J.A.Crump, S.H.Kapiga, N.E.Sam, B.F.Haynes, D.R.Burton, W.C.Koff, L.M.Walker, S.Phogat, R.Wyatt, J.Orwenyo, L.X.Wang, J.Arthos, C.A.Bewley, J.R.Mascola, G.J.Nabel, W.R.Schief, A.B.Ward, I.A.Wilson, and P.D.Kwong (2011).
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.
  Nature, 480, 336-343.
PDB codes: 3tcl 3u1s 3u2s 3u36 3u46 3u4b 3u4e
  21465559 L.T.Da, J.M.Quan, and Y.D.Wu (2011).
Understanding the binding mode and function of BMS-488043 against HIV-1 viral entry.
  Proteins, 79, 1810-1819.  
20463957 A.Hinz, D.Lutje Hulsik, A.Forsman, W.W.Koh, H.Belrhali, A.Gorlani, H.de Haard, R.A.Weiss, T.Verrips, and W.Weissenhorn (2010).
Crystal Structure of the Neutralizing Llama V(HH) D7 and Its Mode of HIV-1 gp120 Interaction.
  PLoS One, 5, e10482.
PDB code: 2xa3
20194785 C.F.Abrams, and E.Vanden-Eijnden (2010).
Large-scale conformational sampling of proteins using temperature-accelerated molecular dynamics.
  Proc Natl Acad Sci U S A, 107, 4961-4966.  
20434359 C.Hager-Braun, E.O.Hochleitner, M.K.Gorny, S.Zolla-Pazner, R.J.Bienstock, and K.B.Tomer (2010).
Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
  J Am Soc Mass Spectrom, 21, 1687-1698.  
20089658 D.P.Leaman, H.Kinkead, and M.B.Zwick (2010).
In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1.
  J Virol, 84, 3382-3395.  
20220841 H.W.Virgin, and B.D.Walker (2010).
Immunology and the elusive AIDS vaccine.
  Nature, 464, 224-231.  
20718047 I.Shrivastava, and J.M.LaLonde (2010).
Fluctuation dynamics analysis of gp120 envelope protein reveals a topologically based communication network.
  Proteins, 78, 2935-2949.  
20888479 J.Liu, E.R.Wright, and H.Winkler (2010).
3D visualization of HIV virions by cryoelectron tomography.
  Methods Enzymol, 483, 267-290.  
20679402 J.Pietzsch, J.F.Scheid, H.Mouquet, F.Klein, M.S.Seaman, M.Jankovic, D.Corti, A.Lanzavecchia, and M.C.Nussenzweig (2010).
Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness.
  J Exp Med, 207, 1995-2002.  
20192810 J.R.Mascola, and D.C.Montefiori (2010).
The role of antibodies in HIV vaccines.
  Annu Rev Immunol, 28, 413-444.  
20523901 J.S.Klein, and P.J.Bjorkman (2010).
Few and far between: how HIV may be evading antibody avidity.
  PLoS Pathog, 6, e1000908.  
20643940 K.J.Doores, C.Bonomelli, D.J.Harvey, S.Vasiljevic, R.A.Dwek, D.R.Burton, M.Crispin, and C.N.Scanlan (2010).
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens.
  Proc Natl Acad Sci U S A, 107, 13800-13805.  
20660185 L.Kong, C.C.Huang, S.J.Coales, K.S.Molnar, J.Skinner, Y.Hamuro, and P.D.Kwong (2010).
Local conformational stability of HIV-1 gp120 in unliganded and CD4-bound states as defined by amide hydrogen/deuterium exchange.
  J Virol, 84, 10311-10321.  
20299194 L.M.Walker, and D.R.Burton (2010).
Rational antibody-based HIV-1 vaccine design: current approaches and future directions.
  Curr Opin Immunol, 22, 358-366.  
20538861 M.Pancera, J.S.McLellan, X.Wu, J.Zhu, A.Changela, S.D.Schmidt, Y.Yang, T.Zhou, S.Phogat, J.R.Mascola, and P.D.Kwong (2010).
Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.
  J Virol, 84, 8098-8110.
PDB codes: 3lrs 3mme
20080564 M.Pancera, S.Majeed, Y.E.Ban, L.Chen, C.C.Huang, L.Kong, Y.D.Kwon, J.Stuckey, T.Zhou, J.E.Robinson, W.R.Schief, J.Sodroski, R.Wyatt, and P.D.Kwong (2010).
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility.
  Proc Natl Acad Sci U S A, 107, 1166-1171.
PDB codes: 3jwd 3jwo
20357769 R.Diskin, P.M.Marcovecchio, and P.J.Bjorkman (2010).
Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity.
  Nat Struct Mol Biol, 17, 608-613.
PDB codes: 3lmj 3lqa
20392850 S.D.Taylor, S.R.Leib, S.Carpenter, and R.H.Mealey (2010).
Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
  J Virol, 84, 6536-6548.  
20949103 S.Gnanakaran, M.G.Daniels, T.Bhattacharya, A.S.Lapedes, A.Sethi, M.Li, H.Tang, K.Greene, H.Gao, B.F.Haynes, M.S.Cohen, G.M.Shaw, M.S.Seaman, A.Kumar, F.Gao, D.C.Montefiori, and B.Korber (2010).
Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.
  PLoS Comput Biol, 6, e1000955.  
20089638 S.H.Xiang, A.Finzi, B.Pacheco, K.Alexander, W.Yuan, C.Rizzuto, C.C.Huang, P.D.Kwong, and J.Sodroski (2010).
A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.
  J Virol, 84, 3147-3161.  
20616231 T.Zhou, I.Georgiev, X.Wu, Z.Y.Yang, K.Dai, A.Finzi, Y.D.Kwon, J.F.Scheid, W.Shi, L.Xu, Y.Yang, J.Zhu, M.C.Nussenzweig, J.Sodroski, L.Shapiro, G.J.Nabel, J.R.Mascola, and P.D.Kwong (2010).
Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.
  Science, 329, 811-817.
PDB code: 3ngb
20220821 W.C.Koff (2010).
Accelerating HIV vaccine development.
  Nature, 464, 161-162.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer